Table 1 Clinico-pathological characteristics of the cohort.
From: Concordance of HER2-low scoring in breast carcinomas among pathologists
Age (years) | Median (IQR) | 65 (59; 78) |
|---|---|---|
Histologic type | Invasive NST | 14 (70%) |
Tubular | 1 (5%) | |
Mucinous | 1 (5%) | |
Invasive micropapillary | 1 (5%) | |
Mixed | 1 (5%) | |
Adenocarcinoma with apocrine differentiation | 1 (5%) | |
Invasive lobular | 1 (5%) | |
ER status | Negative | 1 (5%) |
Positive | 19 (95%) | |
PgR status | Negative | 3 (15%) |
Positive | 17 (85%) | |
HER2 original score | 0 | 8 (40%) |
1+ | 9 (45%) | |
2 + SISH negative | 1 (5%) | |
3+ | 2 (10%) |
